NewKerala.com

Hyderabad Aims to Be Global Life Sciences Capital, Says CM Revanth Reddy

Telangana Chief Minister A. Revanth Reddy inaugurated BioAsia 2026, asserting Hyderabad's potential to evolve from a global vaccine capital into the world's life sciences capital. He highlighted the state's strengths, including a clear policy, skilled workforce, and over Rs 73,000 crore in recent life sciences investments. Industries Minister D. Sridhar Babu outlined a target of $25 billion in investments and 500,000 jobs by 2030 to position Telangana among the world's top three life sciences clusters. The event, attended by thousands of global delegates, also saw Prof Bruce Levine receive the Genome Valley Excellence Award.

Key Points: Hyderabad: From Vaccine to Global Life Sciences Capital

  • Hyderabad's rise from vaccine capital
  • $25B investment & 5L jobs target by 2030
  • Launch of Next-Gen Life Sciences Policy
  • BioAsia conference's global stature
3 min read

Hyderabad has potential to become global life sciences capital: CM

Telangana CM Revanth Reddy outlines Hyderabad's rise as a global life sciences hub with massive investments and a new policy at BioAsia 2026.

"From bulk drugs to biologics, from manufacturing to innovation, from India to the world, Telangana is moving up the value chain. - Chief Minister A. Revanth Reddy"

Hyderabad, Feb 17

Telangana Chief Minister A. Revanth Reddy said on Tuesday that Hyderabad has the potential to rise from global vaccine capital to become global life sciences capital.

Inaugurating BioAsia 2026 along with IT & Industries Minister D. Sridhar Babu, he stated that the annual event stands as proof of Hyderabad's success as a life sciences hub.

He expressed confidence that BioAsia would soon be recognised on the lines of the World Economic Forum organised in Davos.

The Chief Minister highlighted Telangana's strengths, which will support its rise from being a global vaccine capital to become global life sciences capital. He listed strong vision and clear policy, availability of highly qualified human resources, and great educational institutions as the strengths of Telangana.

He noted that Hyderabad is a global hub for Global Capability Centres (GCCs), with excellence in research and design.

The Chief Minister mentioned the recent launch of the Telangana Next-Gen Life Sciences Policy at Davos, the expansion of Genome Valley, the launch of 1Bio or world-class research and innovation, the acceleration of Green Pharma City, and the opening of various global capability centres in Hyderabad.

"In the last two years, we have received over Rs 73,000 crore investments in life sciences," he said.

Hyderabad is the preferred destination to set up GCCs, build innovation engines, design molecules and drugs, manage clinical analytics, build AI platforms and drive digital manufacturing, he added.

Considering the massive turnout from around the world at BioAsia, the Chief Minister said, the conference could surpass its name and be renamed as Bio-World.

He highlighted the presence of major thought and business leaders in pharma, bio-sciences, bio-tech, bulk drugs, vaccines, and healthcare in Hyderabad.

He claimed that Hyderabad has emerged as a trusted, stable, and future-ready ecosystem. "From bulk drugs to biologics, from manufacturing to innovation, from India to the world, Telangana is moving up the value chain," he said.

Minister Sridhar Babu said that the state is targeting $25 billion in life sciences investments and 5 lakh jobs by 2030, with a clear roadmap to position Telangana among the world's Top three life sciences clusters. "Telangana is moving beyond supply-led manufacturing to solution-driven global leadership by building a ready-to-work talent pool in mRNA, gene editing, and AI-led drug discovery, while strengthening Hyderabad as a hub for next-generation innovation and medical tourism," he said.

BioAsia 2026 saw participation of more than 4,000 delegates representing 500 top companies of the Lifesciences ecosystem from all over the world.

The Chief Minister presented Prof Bruce Levine, from the University of Pennsylvania, with the Genome Valley Excellence Award.

- IANS

Share this article:

Reader Comments

S
Sarah B
As someone working in a GCC here, I can confirm the ecosystem is world-class. The convergence of AI, research, and manufacturing talent in one city is rare. Hope the infrastructure (traffic, housing) keeps pace with this growth though!
V
Vikram M
Promises are good, but execution is key. Previous governments also made big claims. Need to see these policies actually helping local MSMEs and startups, not just attracting foreign MNCs. The 5 lakh jobs promise must include quality roles for our graduates.
P
Priya S
So proud of my city! 🎉 From vaccines during COVID to now aiming for global leadership in life sciences. The emphasis on mRNA and gene editing is forward-thinking. Hope this creates more opportunities for women scientists and researchers in Hyderabad.
R
Rohit P
Good vision, but what about the environmental cost? "Green Pharma City" needs to be truly green. We've seen issues with pharma pollution in the past. Growth should be sustainable for the people already living here.
M
Michael C
Attending BioAsia this year. The energy and global participation were incredible. Hyderabad's advantage is its strong academic-industry link with institutes like IICT and universities. If they get the innovation funding right, they can definitely challenge Boston and Basel.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50